Envoy Medical, Inc. (COCH)
NASDAQ: COCH · Real-Time Price · USD
0.7003
+0.0297 (4.43%)
Aug 3, 2026, 2:42 PM EDT - Market open
Envoy Medical Stock Forecast
Stock Price Forecast
According to 2 analysts polled by S&P Global, Envoy Medical stock has a consensus rating of "Strong Buy" and an average price target of $2.25. The average 1-year stock price forecast is 221.29% higher than the current stock price, while the lowest is $2.00 (+185.59%) and the highest is $2.50 (+256.99%).
Price Target: $2.25 (+221.29%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Envoy Medical stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Mar '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 2 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 2 | 1 | 1 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Lucid Capital | Lucid Capital | Buy Initiates $2 | Buy | Initiates | $2 | +185.59% | Jul 27, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $2.5 | Buy | Reiterates | $2.5 | +256.99% | Jul 15, 2026 |
Financial Forecast
Revenue This Year
259.50K
from 241.00K
Increased by 7.68%
Revenue Next Year
320.00K
from 259.50K
Increased by 23.31%
EPS This Year
-0.30
from -1.23
EPS Next Year
-0.23
from -0.30
EPS and Forward PE are based on non-GAAP adjusted numbers.